Silencing of Tropomyosin 1 suppresses the proliferation, invasion and metastasis of oral squamous cell carcinoma in vitro

[1]  H. Kawamata,et al.  Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications , 2022, Cancers.

[2]  Nirali Chauhan,et al.  Expression of microRNA-21 in saliva and tumor tissue of patients with oral squamous cell carcinoma: a predictor of cervical lymph node metastasis. , 2021, Oral surgery, oral medicine, oral pathology and oral radiology.

[3]  Yanping Dai,et al.  Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1 , 2021, Cancer cell international.

[4]  C. R. Leemans,et al.  Head and neck squamous cell carcinoma , 2020, Nature Reviews Disease Primers.

[5]  C. la Vecchia,et al.  Global trends in oral and pharyngeal cancer incidence and mortality , 2020, International journal of cancer.

[6]  Yiping Li,et al.  Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma , 2017, PloS one.

[7]  Chunxi Wang,et al.  Clinical and tumor significance of tropomyosin-1 expression levels in renal cell carcinoma. , 2015, Oncology reports.

[8]  S. Yamada,et al.  MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/β-Catenin Pathway by Targeting DKK2 , 2014, Pathology & Oncology Research.

[9]  Wei Zheng,et al.  Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma. , 2013, International journal of oncology.

[10]  M. Zare,et al.  Downregulation of tropomyosin‐1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation , 2012, Molecular carcinogenesis.

[11]  Michael A. S. Jewett,et al.  The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. , 2012, The Journal of molecular diagnostics : JMD.

[12]  Jungil Choi,et al.  4'-Acetoamido-4-hydroxychalcone, a chalcone derivative, inhibits glioma growth and invasion through regulation of the tropomyosin 1 gene. , 2010, Biochemical and biophysical research communications.

[13]  Y. Ueyama,et al.  Proteomic analysis for nuclear proteins related to tumour malignant progression: a comparative proteomic study between malignant progressive cells and regressive cells. , 2010, Anticancer research.

[14]  Miran Rems,et al.  Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer , 2009, BMC Cancer.

[15]  D. Toncheva,et al.  Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. , 2008, Clinical biochemistry.

[16]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[17]  Shuomin Zhu,et al.  MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.

[18]  R. Falcioni,et al.  Resensitization of breast cancer cells to anoikis by Tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion , 2005, Oncogene.

[19]  N. Iizuka,et al.  Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines , 2005, Proteomics.

[20]  S. Perry.  Vertebrate tropomyosin: distribution, properties and function , 2004, Journal of Muscle Research & Cell Motility.

[21]  M. Willingham,et al.  Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors , 2003, Oncogene.

[22]  G. O'Neill,et al.  Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma , 2003, British Journal of Cancer.

[23]  S. Bharadwaj,et al.  Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. , 2002, Cancer letters.

[24]  K H Kim,et al.  Deciphering the design of the tropomyosin molecule , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Jörnvall,et al.  Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry , 2001, Cellular and Molecular Life Sciences CMLS.

[26]  D. Helfman,et al.  Functional properties of non-muscle tropomyosin isoforms. , 1994, Current opinion in cell biology.

[27]  J. Hamada,et al.  Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). , 1992, British Journal of Cancer.

[28]  Y. Niho,et al.  Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma. , 1987, Journal of the National Cancer Institute.